CLINICAL_TRIALS
trial_result
· 2020-10-20
Clinical Trial Update: Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder [Phase 2]
Summary
Phase 2 trial investigating tocilizumab augmentation in treatment-refractory major depressive disorder; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2020-10-20